|LE Magazine January 2001 |
Continued from Page 1
Page 3 of 3
1. Penglis PS, et al. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J Immunol 2000 Aug 1;165(3):1605-11.
2. Takahashi T, et al. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 Feb;85(2):135-41.
3. Hrycaj P, et al. Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis. Clin Rheumatol 1995 Jul;14(4):434-40.
4. Fischer BA, et al. Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 2000 Aug 1;50(3):236-42.
5. Jeng KC, et al. Collagen induces cytokine production by synovial fluid mononuclear cells in rheumatoid arthritis. Immunol Lett 1995 Feb;45(1-2):13-7.
6. Anker SD, et al. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol 1999 May;14(3):211-6, Review.
7. Patiag D, et al. Effects of tumour necrosis factor-alpha and inhibition of protein kinase C on glucose uptake in L6 myoblasts. Clin Sci (Colch) 2000 Oct 1;99(4):303-307.
8. Wang HB, et al. Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis. Int Immunol 2000 Oct;12(10):1381-1388.
9. Lechleitner M, et al. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 2000 Jul;248(1):67-76.
10. Gattorno M, et al. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schonlein purpura and pediatric systemic lupus erythematosus. J Rheumatol 2000 Sep;27(9):2251-5.
11. Nordahl S, et al. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg 2000 May;58(5):525-30.
12. Breedveld F. New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis. Eur Cytokine Netw 1998 Sep;9(3):233-8.
13. Smith MD, et al. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997 Feb;24(2):365-71.
14. Sugaya K, et al. New anti-inflammatory treatment strategy in Alzheimer's disease. Jpn J Pharmacol 2000 Feb;82(2):85-94.
15. Rahman MA, et al. Effects of dietary fish oil on the induction of experimental membranous nephropathy in the rat. Lab Invest 1991 Mar;64(3):371-6.
16. Hawthorne AB, et al. High dose eicosapentaenoic acid ethyl ester: effects on lipids and neutrophil leukotriene production in normal volunteers. Br J Clin Pharmacol 1990 Aug;30(2):187-94.
17. Akisu M, et al. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing Enterocolitis in young mice. n-3 fatty acids alter platelet-activating factor and Leukotriene B4 production in the intestine. Biol Neonate 1998;74(1):31-8.
18. Kikuchi S, et al. Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 1998 Mar;58(3):243-8.
19. Engstrom K, et al. Whole blood production of thromboxane, prostacyclin and leukotriene B4 after dietary fish oil supplementation in man: effect of vitamin E. Prostaglandins Leukot Essent Fatty Acids 1996 Jun;54(6):419-25.
20. Peterson LD, et al. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 1998 Feb;33(2):171-80.
21. Bartram HP, et al. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 1993 Nov;105(5):1317-22.
22. Sperling RI, et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987 Sep;30(9):988-97.
23. Conquer JA, et al. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb Res 1999 Nov 1;96(3):239-50.
24. Venkatraman JT, et al. Effects of dietary omega-3 and omega-6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model for rheumatoid arthritis. J Am Coll Nutr 1999 Dec;18(6):602-13.
25. Lo CJ, et al., Fish Oil Decreases Macrophage Tumor Necrosis Factor Gene Transcription by Altering the NFkappaB Activity. J Surg Res 1999 Apr;82(2):216-221.
26. Caughey GE, et al. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996 Jan;63(1):116-22.
27. Espersen GT, et al. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 1992 Sep;11(3):393-5.
28. Curtis CL, et al. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000 Jan 14;275(2):721-4.
29. Khalfoun B, et al. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997;400B:589-97.
30. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997;41(4):203-34.
31. Teucher T, et al. [Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract]. Arzneimittelforschung 1996 Sep;46(9):906-10.
32. Obertreis B, et al. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum urticae dioicae foliorum. Arzneimittelforschung 1996 Apr;46(4):389-94. Published erratum appears in Arzneimittelforschung 1996 Sep;46(9):936.
33. Riehemann K, et al. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kappaB. FEBS Lett 1999 Jan 8;442(1):89-94.
34. Chrubasik S, et al. Evidence for antirheumatic effectiveness of Herba Urticae in acute arthritis: a pilot study. Phytomedicine 1997 4:105-108.
35. Kiuchi F, et al. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992 Feb;40(2):387-91.
36. Srivastava KC, et al. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992 Dec;39(4):342-8.
37. Flynn DL, et al. Inhibition of human neutrophil 5-lipooxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med 1986 Oct;24(2-3):195-8.
38. Sharma JN, et al. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 1994 Nov;49(5):314-8.
39. Qiu GX, et al. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittelforschung 1998 May;48(5):469-74.
Return to Page 1